Prevention of mucosally induced uveitis with a HSP60-derived peptide linked to cholera toxin B subunit

P A Phipps; M R Stanford; J B Sun; B G Xiao; J Holmgren; T Shinnick; A Hasan; Y Mizushima; T Lehner

doi:10.1002/immu.200390025

King's College London

King's main site

Research portal

Prevention of mucosally induced uveitis with a HSP60-derived peptide linked to cholera toxin B subunit

Research output: Contribution to journal › Article › peer-review

P A Phipps, M R Stanford, J B Sun, B G Xiao, J Holmgren, T Shinnick, A Hasan, Y Mizushima, T Lehner

Original language	English
Pages (from-to)	224 - 232
Number of pages	9
Journal	European Journal of Immunology
Volume	33
Issue number	1
DOIs	https://doi.org/10.1002/immu.200390025
Published	1 Jan 2003
Additional links	Link to publication in Scopus

King's Authors

Research Groups

King's College London

Abstract

Oral administration of the uveitogenic peptide (aa 336-351) derived from human HSP60 induced clinical and histological manifestations of uveitis in 65.8% (48/73) of Lewis rats. Uveitis was significantly decreased to 16.7% (11/66) in parallel experiments with the peptide linked to recombinant cholera toxin B subunit (rCTB), also given by mouth (x(2) = 34.2, p

View graph of relations

King's College London - Homepage

Prevention of mucosally induced uveitis with a HSP60-derived peptide linked to cholera toxin B subunit

King's Authors

Research Groups

Abstract

By the same authors

With some of the same researchers

From the same journal